Agf Investments Inc. Vertex Pharmaceuticals Inc Transaction History

Agf Investments Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$221.42 - $260.97 $1.03 Million - $1.22 Million	-4,666 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$177.01 - $223.45 $153,998 - $194,401	870 Added 22.92%	4,666 $1.03 Million
Q3 2021 Nov 10, 2021	BUY	$181.39 - $202.99 $27,027 - $30,245	149 Added 4.09%	3,796 $689,000
Q2 2021 Aug 10, 2021	BUY	$187.49 - $221.1 $28,873 - $34,049	154 Added 4.41%	3,647 $735,000
Q1 2021 May 14, 2021	SELL	$207.02 - $241.31 $719,601 - $838,793	-3,476 Reduced 49.88%	3,493 $751,000
Q4 2020 Feb 08, 2021	BUY	$207.01 - $276.09 $226,054 - $301,490	1,092 Added 18.58%	6,969 $1.65 Million
Q3 2020 Nov 12, 2020	BUY	$255.65 - $303.1 $785,612 - $931,426	3,073 Added 109.59%	5,877 $1.6 Million
Q2 2020 Aug 11, 2020	SELL	$225.48 - $295.8 $33,145 - $43,482	-147 Reduced 4.98%	2,804 $814,000
Q1 2020 May 08, 2020	BUY	$199.77 - $247.81 $589,521 - $731,287	2,951 New	2,951 $702,000

1,726

221M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Agf Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Agf Investments Inc. with notifications on news.